v3.26.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Preferred Stock
Series D
Preferred Stock
Series E
Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Statutory Reserve
Accumulate Other Comprehensive Loss
Noncontrolling Interest
Total
Balance at Dec. 31, 2023 $ 9,000,000 $ 11,000,000 $ 74 $ 67,886,082 $ (522,500) $ (79,769,731) $ 6,578 $ (231,727) $ 7,368,776
Balance (in Shares) at Dec. 31, 2023 9,000 11,000 736,769              
Balance (in Shares) at Dec. 31, 2023               (3,467)          
Issuance of common stock as convertible note payable commitment fee $ 3 320,543 320,546
Issuance of common stock as convertible note payable commitment fee (in Shares)           33,800              
Sale of common stock, net $ 28 2,544,283 2,544,311
Sale of common stock, net (in Shares)           281,843              
Issuance of common stock upon cashless exercise of stock warrants $ 4 (4)
Issuance of common stock upon cashless exercise of stock warrants (in Shares)           42,381              
Issuance of common stock for services $ 15 530,335 530,350
Issuance of common stock for services (in Shares)           145,153              
Reclassification of derivative liability to equity 2,354 2,354
Sale of Series C Convertible Preferred Stock $ 3,500,000   3,500,000
Sale of Series C Convertible Preferred Stock (in Shares)     3,500                    
Issuance of pre-funded warrants 688,794 688,794
Stock-based compensation 51,159 51,159
Shares issued for adjustments for 1:15 reverse split $ 21 (21)
Shares issued for adjustments for 1:15 reverse split (in Shares)           206,033              
Foreign currency translation adjustment (273) (273)
Net loss for the year (7,903,394) (7,903,394)
Balance at Dec. 31, 2024 $ 9,000,000 $ 11,000,000 $ 3,500,000 $ 145 72,023,525 $ (522,500) (87,673,125) 6,578 (232,000) $ 7,102,623
Balance (in Shares) at Dec. 31, 2024 9,000 11,000 3,500   1,445,979              
Balance (in Shares) at Dec. 31, 2024               (3,467)         3,467
Issuance of common stock upon cashless exercise of stock warrants   $ 19 (19)
Issuance of common stock upon cashless exercise of stock warrants (in Shares)           186,877              
Issuance of common stock for services   $ 2 111,230 111,232
Issuance of common stock for services (in Shares)           22,278              
Reclassification of derivative liability to equity   18,853 18,853
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock $ (9,000,000) $ 8,837,527   162,473
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock (in Shares) (9,000)     5,000                  
Series B Convertible Preferred Stock extinguished related to sale of equity method investment $ (11,000,000)   2,348,695 (8,651,305)
Series B Convertible Preferred Stock extinguished related to sale of equity method investment (in Shares)   (11,000)                      
Stock-based compensation   9,159 9,159
Foreign currency translation adjustment   279 279
Net loss for the year   (2,482,111) (2,482,111)
Balance at Mar. 31, 2025 $ 3,500,000 $ 8,837,527   $ 166 74,673,916 $ (522,500) (90,155,236) 6,578 (231,721) (3,891,270)
Balance (in Shares) at Mar. 31, 2025 3,500 5,000   1,655,134              
Balance (in Shares) at Mar. 31, 2025               (3,467)          
Balance at Dec. 31, 2024 $ 9,000,000 $ 11,000,000 $ 3,500,000 $ 145 72,023,525 $ (522,500) (87,673,125) 6,578 (232,000) $ 7,102,623
Balance (in Shares) at Dec. 31, 2024 9,000 11,000 3,500   1,445,979              
Balance (in Shares) at Dec. 31, 2024               (3,467)         3,467
Issuance of common stock as convertible note payable commitment fee $ 1 26,799 $ 26,800
Issuance of common stock as convertible note payable commitment fee (in Shares)           10,000              
Issuance of common stock upon cashless exercise of stock warrants $ 43 (43)
Issuance of common stock upon cashless exercise of stock warrants (in Shares)           429,181              
Issuance of common stock for services $ 61 1,880,725 1,880,786
Issuance of common stock for services (in Shares)           606,494              
Reclassification of derivative liability to equity 176,529 176,529
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock $ (9,000,000) $ 8,837,527 162,473
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock (in Shares) (9,000)     5,000                  
Series B Convertible Preferred Stock extinguished related to sale of equity method investment $ (11,000,000) 2,348,695 (8,651,305)
Series B Convertible Preferred Stock extinguished related to sale of equity method investment (in Shares)   (11,000)                      
Sale of Series C Convertible Preferred Stock $ 290,000 290,000
Sale of Series C Convertible Preferred Stock (in Shares)     300                    
Series E Convertible Preferred Stock issued for acquisition $ 14,916,753 14,916,753
Series E Convertible Preferred Stock issued for acquisition (in Shares)         19,500                
Sale of common stock and warrants, net $ 12 450,488 450,500
Sale of common stock and warrants, net (in Shares)           121,200              
Stock-based compensation (13,409) (13,409)
Conversion of convertible note payable and accrued interest into common stock $ 224 2,244,398 2,244,622
Conversion of convertible note payable and accrued interest into common stock (in Shares)           2,244,622              
Loss on extinguishment of debt recognized 9,076,587 9,076,587
Foreign currency translation adjustment (9,402) (9,402)
Net loss for the year (18,260,976) (18,260,976)
Balance at Dec. 31, 2025 $ 3,790,000 $ 8,837,527 $ 14,916,753 $ 486 88,376,767 $ (522,500) (105,934,101) 6,578 (241,402) $ 9,230,108
Balance (in Shares) at Dec. 31, 2025 3,800 5,000 19,500 4,857,476              
Balance (in Shares) at Dec. 31, 2025               (3,467)         3,467
Issuance of common stock upon cashless exercise of pre-funded stock warrants     $ 35 (35)
Issuance of common stock upon cashless exercise of pre-funded stock warrants (in Shares)           354,257              
Issuance of common stock upon cashless exercise of stock warrants     $ 127 (127)
Issuance of common stock upon cashless exercise of stock warrants (in Shares)           1,268,672              
Conversion of Series C Preferred Stock into common stock     $ (723,000) $ 30 722,970
Conversion of Series C Preferred Stock into common stock (in Shares)     (723)     300,000              
Issuance of common stock for services     $ 50 522,750 522,800
Issuance of common stock for services (in Shares)           505,000              
Sales of securities from the February 2026 private placement, net     $ 49 2,756,763 2,756,812
Sales of securities from the February 2026 private placement, net (in Shares)           490,197              
Sale of subsidiary (Note 3)     1,861,266 1,861,266
Reclassification of derivative liability to equity     1,281,603 1,281,603
Conversion of convertible note payable and accrued interest into common stock     $ 55 551,419 551,474
Conversion of convertible note payable and accrued interest into common stock (in Shares)           551,474              
Foreign currency translation adjustment     (311) (311)
Net loss for the year     (4,479,695) (4,479,695)
Balance at Mar. 31, 2026     $ 3,067,000 $ 8,837,527 $ 14,916,753 $ 832 $ 96,073,376 $ (522,500) $ (110,413,796) $ 6,578 $ (241,713)   $ 11,724,057
Balance (in Shares) at Mar. 31, 2026     3,077 5,000 19,500 8,327,076              
Balance (in Shares) at Mar. 31, 2026               (3,467)         3,467